Elizabeth C. Riley M.D., FACP

Elizabeth C. Riley M.D., FACP

Elizabeth C. Riley M.D.

Elizabeth C. Riley M.D., FACP

  • Associate Professor of Medicine
James Graham Brown Cancer Center
530 South Jackson Street
Louisville, KY 40202

502-852-2522 - Academic Office
502-562-4370 - Patient Appointments


Clinical Expertise
Medical Oncology-Breast; Hematology

 

Board Certifications

  • American Board of Internal Medicine -
    Medical Oncology / Hematology

Education and Training

  • Medical School: University of Louisville
  • Residency: Beth Israel Deaconess Medical Center - Harvard Medical School
  • Fellowship: Beth Israel Deaconess Medical Center - Harvard Medical School

 

    Recent Publications

          • Boone SD, Baumgartner KB, Baumgartner RN, Connor AE, John EM, Giuliano AR, Hines LM, Rai SN, Riley EC, Pinkston CM, Wolff RK, Slattery ML. Active and passive cigarette smoking and mortality among Hispanic and non-Hispanic white women diagnosed with invasive breast cancer. Ann Epidemiol. 2015 Nov;25(11):824-31. doi: 10.1016/j.annepidem.2015.08.007. Epub 2015 Aug 28. PubMedPMID: 26387598; PubMed Central PMCID: PMC4609618.
          • Das N, Baumgartner RN, Riley EC, Pinkston CM, Yang D, Baumgartner KB. Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors. J Cancer Surviv. 2015 Sep;9(3):422-30. doi: 10.1007/s11764-014-0416-9. Epub 2015 Apr 26. PubMed PMID: 25913877.
          • Shaughnessy JN, Meena RA, Dunlap NE, Jain D, Riley EC, Quillo AR, Dragun AE. Efficacy of concurrent chemoradiotherapy for patients with locally recurrent or advanced inoperable breast cancer. Clin Breast Cancer. 2015 Apr;15(2):135-42. doi: 10.1016/j.clbc.2014.10.007. Epub 2014 Oct 22. PubMed PMID: 25454741.
          • Torres D, Myers JA, Eshraghi LW, Riley EC, Soliman PT, Milam MR. Risk factors for the development of uterine cancer in breast cancer survivors: an army of women study. Ann Surg Oncol. 2015;22(6):1974-9. doi: 10.1245/s10434-014-4193-5. Epub 2014 Nov 1. PubMed PMID: 25361886.
          • Barry PN, Riley EC, Pan J, Crew JB, Lee K, Jain D, Kruse B, Quillo AR, Rai S, Dragun AE. Delay of adjuvant chemotherapy after elective mastectomy and immediate reconstruction in breast-conservation candidates: a matched-pair analysis. Am J Clin Oncol. 2014 Dec;37(6):575-9. doi: 10.1097/COC.0b013e318280d79f. PubMed PMID: 23466579.
          • Mizuguchi S, Barkley L, Rai S, Pan J, Roland L, Crawford S, Riley EC. Mobile Mammography, Race, and Insurance: Use Trends Over a Decade at a Comprehensive Urban Cancer Center. J Oncol Pract. 2014 Nov 4. pii: JOP.2014.001477. [Epub ahead of print] PubMed PMID: 25371543.
          • Boone SD, Baumgartner KB, Baumgartner RN, Connor AE, Pinkston CM, Rai SN, Riley EC, Hines LM, Giuliano AR, John EM, Stern MC, Torres-Mejía G, Wolff RK, Slattery ML. Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study. Cancer Causes Control. 2014 Nov;25(11):1461-71. doi: 10.1007/s10552-014-0448-5. Epub 2014 Aug 5. PubMed PMID: 25088806; PubMed Central PMCID: PMC4435673.
          • Dragun AE, Pan J, Riley EC, Kruse B, Wilson MR, Rai S, Jain D. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Am J Clin Oncol. 2013 Aug;36(4):375-80. doi: 10.1097/COC.0b013e318248da47. PubMed PMID: 22643566.
          • Dragun AE, Quillo AR, Riley EC, Roberts TL, Hunter AM, Rai SN, Callender GG, Jain D, McMasters KM, Spanos WJ. A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction. Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):e123-8. doi: 10.1016/j.ijrobp.2012.10.021. Epub 2012 Nov 27. PubMed PMID: 23195779.
          • Riley EC, Moy B. Ethical challenges: caring for the underinsured,geographically disadvantaged patient. J Oncol Pract. 2012 Jul;8(4):215-8. doi: 10.1200/JOP.2012.000603. PubMed PMID: 23180985; PubMed Central PMCID: PMC3396816.